New in Cardio-Oncology: VMAT shows no early cardiac function decline for left-sided breast cancer patients

Memorial Sloan Kettering Radiation Oncology shared on X:

“New in Cardio-Oncology breast cancer, Lior Braunstein:

VMAT for left-sided breast cancer RNI yielded no significant early decrement in echocardiographic parameters of cardiac function.

No patient exhibited significant LVEF changes or sustained decrements in strain.”

Source: Memorial Sloan Kettering Radiation Oncology/X

Echocardiographic functional outcomes following regional nodal irradiation for breast cancer using volumetric modulated arc therapy.

Authors: Anthony F. Yu, Charlie White, Zhigang Zhang, Jennifer E. Liu, Erin F Gillespie, Beryl McCormick, Atif J Khan, Richard M. Steingart, Simon N Powell, Oren Cahlon, Lior Z. Braunstein.